Key result
Native T1 and ECV values are higher in myocardial diseases versus controls despite overlapping ranges.
Why the study?
To determine native T1 and extracellular volume fraction across distinct types of myocardial disease and coronary artery disease compared to controls.
Does native T1 mapping and extracellular volume fraction (ECV) differentiate myocardial diseases from normal controls in routine clinical practice?
Observational (n=1,188)
Does native T1 mapping and extracellular volume fraction (ECV) differentiate myocardial diseases from normal controls in routine clinical practice?
Native T1 mapping and ECV are significantly elevated in patients with cardiomyopathies and CAD compared to normal controls, with the greatest diagnostic utility seen in cardiac amyloidosis despite overlapping values among other conditions.
Overlapping T1/ECV values limit differentiation in practice; leaves open validation of disease-specific thresholds in prospective cohorts.
BACKGROUND: This study aimed to determine native T1 and extracellular volume fraction (ECV) in distinct types of myocardial disease, including amyloidosis, dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), myocarditis and coronary artery disease (CAD), compared to controls. METHODS: We retrospectively enrolled patients with distinct types of myocardial disease, CAD patients, and control group (no known heart disease and negative CMR study) who underwent 3.0 Tesla CMR with routine T1 mapping. The region of interest (ROI) was drawn in the myocardium of the mid left ventricular (LV) short axis slice and at the interventricular septum of mid LV slice. ECV was calculated by actual hematocrit (Hct) and synthetic Hct. T1 mapping and ECV was compared between myocardial disease and controls, and between CAD and controls. Diagnostic yield and cut-off values were assessed. RESULTS: A total of 1188 patients were enrolled. The average T1 values in the control group were 1304 ± 42 ms at septum, and 1294 ± 37 ms at mid LV slice. The average T1 values in patients with myocardial disease and CAD were significantly higher than in controls (1441 ± 72, 1349 ± 59, 1345 ± 59, 1355 ± 56, and 1328 ± 54 ms for septum of amyloidosis, DCM, HCM, myocarditis, and CAD). Native T1 of the mid LV level and ECV at septum and mid LV with actual and synthetic Hct of patients with myocardial disease or CAD were significantly higher than in controls. CONCLUSIONS: Although native T1 and ECV of patients with cardiomyopathy and CAD were significantly higher than controls, the values overlapped. The greatest clinical utilization was found for the amyloidosis group.
No takes yet. Share an insight, caveat, or question.
Thongsongsang et al. (2021) conducted an observational in Myocardial diseases and coronary artery disease (n=1,188). Native T1 mapping and extracellular volume fraction (ECV) vs. Controls (no known heart disease and negative CMR) was evaluated on Native T1 and ECV values. Native T1 and ECV values were significantly higher in patients with myocardial diseases compared to controls (e.g., septum T1 1441 ms in amyloidosis vs 1304 ms in controls), though values overlapped.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: